Thomas Niel

Thomas Niel

Expertise: Micro-Cap Stocks, Shareholder Activist Stocks, Value Stocks

Education: Bachelors in Accounting, CFA Program Participant (Completed Level I in 2017)

About Thomas:
Thomas Niel is an investment writer at InvestorPlace. With a professional background in accounting and financial analysis, his understanding of both words and figures pays dividends when writing clear, concise stock analysis.

A value investor at heart, Thomas looks at the fundamentals. Peer analysis and earnings multiples rarely tell the whole story. But, Thomas believes valuation metrics are a great starting point to separate the wheat from the chaff.

His work has appeared at several websites, including Seeking Alpha and TipRanks. Outside of investment research, Thomas provides inbound marketing content to the investment management industry.

You can follow Thomas on Twitter and check out his track record on TipRanks.

Recent Articles

Expect Nvidia Stock to Hold Steady at Best in the Short Term

Even if volatility fears are overblown, it may be difficult for NVDA stock to hit new highs in the months ahead. Wait on this name for now.

7 Deep Value Stocks That Are an Even Better Buy Now After Tanking

Whether they've pulled back as of late or have been depressed for a while, consider these 7 deep value stocks screaming buys.

Multiple Strengths Could Outweigh Recent Concerns for Solana

With much on its side, if you already own Solana, your best move may be to hold onto it. If you haven't bought it yet? Any weakness in the near-term may be a good time to buy.

Keep Algorand on Your Radar as This Crypto Starts to Take Off

Don't "bet the ranch" on it right now, as the opportunity to get in at lower prices may be around the corner. But if you're bullish on crypto's long-term prospects, be sure to include Algorand in your portfolio.

Vinco Ventures Stock Has an Uphill Battle, But You Shouldn’t Write It Off Just Yet

It's best to approach BBIG stock with a critical eye. But given it could soar again, if there proves to be substance to go along with the hype? It's best not to underestimate it.